Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Regul Toxicol Pharmacol ; 147: 105557, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38142814

RESUMO

REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) is a European Union regulation that aims to protect human health and the environment from the risks posed by chemicals. Article 25 clearly states that: "[i]n order to avoid animal testing, testing on vertebrate animals for the purposes of this Regulation shall be undertaken only as a last resort." In practice, however, the standard information requirements under REACH are still primarily filled using animal studies. This paper presents examples illustrating that animal testing is not always undertaken only as a last resort. Six over-arching issues have been identified which contribute to this: (1) non-acceptance of existing animal or non-animal data, (2) non-acceptance of read-across, (3) inflexible administrative processes, (4) redundancy of testing, (5) testing despite animal welfare concerns and (6) testing for cosmetic-only ingredients. We, members of the Animal-Free Safety Assessment (AFSA) Collaboration, who work together to accelerate the global adoption of non-animal approaches for chemical safety assessment, herein propose several recommendations intended to aid the European Commission, the European Chemicals Agency and registrants to protect human health and the environment while avoiding unnecessary animal tests - truly upholding the last resort requirement in REACH.


Assuntos
Bem-Estar do Animal , Animais de Laboratório , Animais , Humanos , União Europeia , Alternativas aos Testes com Animais , Medição de Risco
2.
Front Toxicol ; 4: 1001709, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36310693

RESUMO

Background: Due the increasing need for storage of carbon dioxide (CO2) more individuals are prone to be exposed to high concentrations of CO2 accidentally released into atmosphere, with deleterious consequences. Methods: We tested the effect of increasing CO2 concentrations in humans (6-12%) and rats (10-50%) at varying inhalation times (10-60 min). In humans, a continuous positive airway pressure helmet was used to deliver the gas mixture to the participants. Unrestrained rats were exposed to CO2 in a transparent chamber. In both species regular arterial blood gas samples were obtained. After the studies, the lungs of the animals were examined for macroscopic and microscopic abnormalities. Results: In humans, CO2 concentrations of 9% inhaled for >10 min, and higher concentrations inhaled for <10 min were poorly or not tolerated due to exhaustion, anxiety, dissociation or acidosis (pH < 7.2), despite intact oxygenation. In rats, concentrations of 30% and higher were associated with CO2 narcosis, epilepsy, poor oxygenation and, at 50% CO2, spontaneous death. Lung hemorrhage and edema were observed in the rats at inhaled concentrations of 30% and higher. Conclusion: This study provides essential insight into the occurrence of physiological changes in humans and fatalities in rats after acute exposure to high levels of CO2. Humans tolerate 9% CO2 and retain their ability to function coherently for up to 10 min. These data support reconsideration of the current CO2 levels (<7.5%) that pose a risk to exposed individuals (<7.5%) as determined by governmental agencies to ≤9%.

3.
Toxicol In Vitro ; 44: 11-16, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28595837

RESUMO

To enable selection of novel chemicals for new processes, there is a recognized need for alternative toxicity screening assays to assess potential risks to man and the environment. For human health hazard assessment these screening assays need to be translational to humans, have high throughput capability, and from an animal welfare perspective be harmonized with the principles of the 3Rs (Reduction, Refinement, Replacement). In the area of toxicology a number of cell culture systems are available but while these have some predictive value, they are not ideally suited for the prediction of developmental and reproductive toxicology (DART). This is because they often lack biotransformation capacity, multicellular or multi- organ complexity, for example, the hypothalamus pituitary gonad (HPG) axis and the complete life cycle of whole organisms. To try to overcome some of these limitations in this study, we have used Caenorhabditis elegans (nematode) and Danio rerio embryos (zebrafish) as alternative assays for DART hazard assessment of some candidate chemicals being considered for a new commercial application. Nematodes exposed to Piperazine and one of the analogs tested showed a slight delay in development compared to untreated animals but only at high concentrations and with Piperazine as the most sensitive compound. Total brood size of the nematodes was also reduced primarily by Piperazine and one of the analogs. In zebrafish Piperazine and analogs showed developmental delays. Malformations and mortality in individual fish were also scored. Significant malformations were most sensitively identified with Piperazine, significant mortality was only observed in Piperazine and only at the higest dose. Thus, Piperazine seemed the most toxic compound for both nematodes and zebrafish. The results of the nematode and zebrafish studies were in alignment with data obtained from conventional mammalian toxicity studies indicating that these have potential as developmental toxicity screening systems. The results of these studies also provided reassurance that none of the Piperazines tested are likely to have any significant developmental and/or reproductive toxicity issues to humans when used in their commercial applications.


Assuntos
Caenorhabditis elegans/efeitos dos fármacos , Desenvolvimento Embrionário/efeitos dos fármacos , Piperazinas/toxicidade , Reprodução/efeitos dos fármacos , Peixe-Zebra/embriologia , Animais , Caenorhabditis elegans/embriologia , Embrião não Mamífero , Modelos Animais
4.
Regul Toxicol Pharmacol ; 67(3): 409-20, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24025648

RESUMO

The process streams refined from petroleum crude oil for use in petroleum products are among those designated by USEPA as UVCB substances (unknown or variable composition, complex reaction products and biological materials). They are identified on global chemical inventories with unique Chemical Abstract Services (CAS) numbers and names. The chemical complexity of most petroleum substances presents challenges when evaluating their hazards and can result in differing evaluations due to the varying level of hazardous constituents and differences in national chemical control regulations. Global efforts to harmonize the identification of chemical hazards are aimed at promoting the use of consistent hazard evaluation criteria. This paper discusses a systematic approach for the health hazard evaluation of petroleum substances using chemical categories and the United Nations (UN) Globally Harmonized System (GHS) of classification and labeling. Also described are historical efforts to characterize the hazard of these substances and how they led to the development of categories, the identification of potentially hazardous constituents which should be considered, and a summary of the toxicology of the major petroleum product groups. The use of these categories can increase the utility of existing data, provide better informed hazard evaluations, and reduce the amount of animal testing required.


Assuntos
Substâncias Perigosas/química , Substâncias Perigosas/classificação , Petróleo/classificação , Animais , União Europeia , Regulamentação Governamental , Substâncias Perigosas/toxicidade , Petróleo/toxicidade , Rotulagem de Produtos/legislação & jurisprudência , Rotulagem de Produtos/métodos , Rotulagem de Produtos/normas , Estados Unidos
5.
Eur J Pharmacol ; 509(2-3): 97-108, 2005 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-15733544

RESUMO

Effects of cholinergic drugs on human alpha4beta2 nicotinic acetylcholine receptors expressed in Xenopus oocytes have been investigated in electrophysiological and ligand binding experiments. Atropine, scopolamine, physostigmine, and tacrine combine potentiation of ion current induced by low concentrations of acetylcholine with inhibition of ion current evoked by high concentrations of acetylcholine. Rivastigmine, galanthamine, and dichlorvos cause only inhibition of ion current evoked by low concentrations of acetylcholine. Binding experiments show that the potentiating cholinergic drugs atropine, scopolamine, and physostigmine are competitive ligands of human alpha4beta2 nicotinic acetylcholine receptors. Conversely, the inhibitory cholinergic drugs galanthamine and rivastigmine are non-competitive. The non-competitive drugs are not allosteric, since they do not affect the saturation curve of the radioligand [3H]cytisine. Effects of potentiating cholinergic drugs on nicotinic acetylcholine receptors are consistent with and predicted by a model comprising competitive drug effects at two equivalent agonist recognition sites on the nicotinic acetylcholine receptor combined with non-competitive ion channel block.


Assuntos
Colinérgicos/farmacologia , Receptores Nicotínicos/fisiologia , Acetilcolina/farmacologia , Alcaloides/farmacologia , Animais , Atropina/farmacologia , Azocinas/farmacologia , Ligação Competitiva/efeitos dos fármacos , Inibidores da Colinesterase/farmacologia , Diclorvós/farmacologia , Relação Dose-Resposta a Droga , Feminino , Galantamina/farmacologia , Humanos , Potenciais da Membrana/efeitos dos fármacos , Modelos Biológicos , Nicotina/farmacologia , Oócitos/efeitos dos fármacos , Oócitos/fisiologia , Fenilcarbamatos/farmacologia , Fisostigmina/farmacologia , Plasmídeos/administração & dosagem , Plasmídeos/genética , Quinolizinas/farmacologia , Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Rivastigmina , Escopolamina/farmacologia , Tacrina/farmacologia , Xenopus laevis
6.
Toxicol Sci ; 82(2): 545-54, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15342957

RESUMO

Chronic and acute exposure to organophosphate (OP) pesticides may lead to persistent neurological and neurobehavioral effects, which cannot be explained by acetylcholinesterase (AChE) inhibition alone. It is suggested that other brain proteins are involved. Effects of commonly used organophosphate pesticides on rat neuronal alpha4beta2 nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus laevis oocytes have been investigated using the two-electrode voltage clamp technique. Several OP pesticides, e.g., parathion-ethyl, chlorpyrifos and disulfoton, inhibited the ACh-induced ion current with potencies in the micromolar range. The potency of inhibition increased with increasing concentrations of the agonist ACh. Comparison of the potency of nAChR inhibition with the potency of AChE inhibition demonstrated that some OPs inhibit nAChRs more potently than AChE. Binding experiments on alpha4beta2 nAChRs showed that the OPs noncompetitively interact with nAChRs. The inhibitory effects on nAChRs are adequately described and explained by a sequential two-step mechanism, in which rapidly reversible OP binding to a separate binding site leads to inhibition followed by a stabilization of the blocked state or receptor desensitization. It is concluded that OPs interact directly with neuronal alpha4beta2 nAChRs to inhibit the agonist-induced response. This implicates that neuronal alpha4beta2 nAChRs are additional targets for some OP pesticides.


Assuntos
Inseticidas/farmacologia , Antagonistas Nicotínicos/farmacologia , Compostos Organofosforados/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , Algoritmos , Animais , Ligação Competitiva/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Compostos Bicíclicos Heterocíclicos com Pontes/metabolismo , Inibidores da Colinesterase/farmacologia , Relação Dose-Resposta a Droga , Eletrofisiologia , Humanos , Cinética , Ligantes , Masculino , Modelos Biológicos , Agonistas Nicotínicos/metabolismo , Oócitos/metabolismo , Técnicas de Patch-Clamp , Piridinas/metabolismo , Ratos , Ratos Wistar , Xenopus laevis
7.
Toxicol Sci ; 82(1): 219-27, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15329441

RESUMO

The mechanism by which carbamate pesticides inhibit rat alpha4beta2 nicotinic acetylcholine (ACh) receptors (nAChRs) expressed in Xenopus laevis oocytes has been investigated using the two-electrode voltage clamp technique. Carbaryl, S-ethyl N,N-dipropylthiocarbamate (EPTC), and fenoxycarb inhibit ACh-induced ion currents in a concentration-dependent way. EPTC and fenoxycarb inhibit ion currents induced by 1 mM ACh with 3-fold to 5-fold higher potency than ion currents induced by 1 microM ACh. The potency of carbaryl appears to be independent of ACh concentration. Fenoxycarb displaces (3)H-epibatidine bound to alpha4beta2 (nAChRs) with a K(i) of 750 microM, which is much higher than the functional IC(50) of 2.3-11 microM. This shows that the inhibition of ion current by the carbamate is a noncompetitive effect. Inhibition by fenoxycarb is independent of the state of the ion channel. The rate of onset of inhibition is enhanced, and the rate of reversal of inhibition is reduced, when the concentration of fenoxycarb is increased. The rate of reversal of inhibition is also reduced when the period of exposure to fenoxycarb is increased. The time- and concentration-dependent inhibition of nAChR-mediated ion current by fenoxycarb is accounted for by a two-step mechanism involving a rapid blocked state and a sequential more stably blocked or desensitized state.


Assuntos
Carbamatos , Antagonistas Nicotínicos/toxicidade , Praguicidas/toxicidade , Receptores Nicotínicos/efeitos dos fármacos , Xenopus laevis , Animais , Compostos Bicíclicos Heterocíclicos com Pontes/farmacocinética , Relação Dose-Resposta a Droga , Eletrofisiologia , Feminino , Concentração Inibidora 50 , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Técnicas de Patch-Clamp , Piridinas/farmacocinética , Ratos , Receptores Nicotínicos/metabolismo , Fatores de Tempo , Trítio
8.
Toxicol Appl Pharmacol ; 193(2): 139-46, 2003 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-14644616

RESUMO

Effects of commonly used carbamate pesticides on rat neuronal nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes have been investigated using the two-electrode voltage clamp technique. The potencies of these effects have been compared to the potencies of the carbamates to inhibit rat brain acetylcholinesterase. The potency order of six carbamates to inhibit alpha4beta4 nicotinic receptors is fenoxycarb > EPTC > carbaryl, bendiocarb > propoxur > aldicarb with IC50 values ranging from 3 microM for fenoxycarb to 165 microM for propoxur and >1 mM for aldicarb. Conversely, the potency order of these carbamates to inhibit rat brain acetylcholinesterase is bendiocarb > propoxur, aldicarb > carbaryl > EPTC, fenoxycarb with IC50 values ranging from 1 microM for bendiocarb to 17 microM for carbaryl and > mM for EPTC and fenoxycarb. The alpha4beta2, alpha3beta4, and alpha3beta2 nicotinic acetylcholine receptors are inhibited by fenoxycarb, EPTC, and carbaryl with potency orders similar to that for alpha4beta4 receptors. Comparing the potencies of inhibition of the distinct subtypes of nicotinic acetylcholine receptors shows that the alpha3beta2 receptor is less sensitive to inhibition by fenoxycarb and EPTC. The potency of inhibition depends on the carbamate as well as on a combination of alpha and beta subunit properties. It is concluded that carbamate pesticides affect different subtypes of neuronal nicotinic receptors independently of acetylcholinesterase inhibition. This implicates that neuronal nicotinic receptors are additional targets for some carbamate pesticides and that these receptors may contribute to carbamate pesticide toxicology, especially after long-term exposure.


Assuntos
Acetilcolinesterase/metabolismo , Encéfalo/efeitos dos fármacos , Carbamatos , Inseticidas/toxicidade , Neurônios/efeitos dos fármacos , Receptores Nicotínicos/efeitos dos fármacos , Animais , Encéfalo/enzimologia , Inibidores da Colinesterase/toxicidade , Relação Dose-Resposta a Droga , Concentração Inibidora 50 , Masculino , Potenciais da Membrana/efeitos dos fármacos , Neurônios/metabolismo , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Técnicas de Patch-Clamp , Isoformas de Proteínas , Ratos , Ratos Wistar , Receptores Nicotínicos/metabolismo , Relação Estrutura-Atividade , Xenopus laevis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...